NRX Pharmaceuticals

NRXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$143.742 M

$3.32 +0.91%

Close of 22 Sept 2026

Revenue

$1.23M

#3467 by revenue

Earnings

-$28.6M

Loss-making

Shares outstanding

43,295,767

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#285Korro BioKRRO$152.3M
#286ImmunicIMUX$147.9M
#287NRX PharmaceuticalsNRXP$143.7M
#288Spruce BiosciencesSPRB$143.7M
#289MedicinovaMNOV$142.7M

What if NRX Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$698,312.37

Per share 210,335× higher

Bitcoin $1.74T

$40,226.91

Per share 12,117× higher

Nvidia $5.52T

$127,397.37

Per share 38,373× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for NRX Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.